This company listing is no longer active
A285770 Stock Overview
Life Science Technology Inc. engages in the development of bio-signal measurement devices in South Korea.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Life Science Technology Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩130.00 |
52 Week High | ₩250.00 |
52 Week Low | ₩81.00 |
Beta | 0 |
1 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -96.18% |
5 Year Change | -97.17% |
Change since IPO | -97.62% |
Recent News & Updates
Recent updates
Shareholder Returns
A285770 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | 38.3% | -2.8% | 0.05% |
1Y | n/a | 32.3% | 10.4% |
Return vs Industry: Insufficient data to determine how A285770 performed against the KR Medical Equipment industry.
Return vs Market: Insufficient data to determine how A285770 performed against the KR Market.
Price Volatility
A285770 volatility | |
---|---|
A285770 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.7% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A285770's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A285770's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | n/a | n/a | https://www.lifesciencetechnology.company |
Life Science Technology Inc. engages in the development of bio-signal measurement devices in South Korea. It primarily offers ECG, PPG, body fat analysis, blood pressure measurement, and stress analysis devices. The company was founded in 2007 and is headquartered in Seoul, South Korea.
Life Science Technology Inc. Fundamentals Summary
A285770 fundamental statistics | |
---|---|
Market cap | ₩415.09m |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A285770 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A285770 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A285770 perform over the long term?
See historical performance and comparison